Trial Profile
Biodistribution and Reproducibility of Ga-68 PSMA-HBED-CC Positron Emission Tomography in Patients With Biopsy Proven Metastatic Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 18 May 2023
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 29 Jan 2021 Planned End Date changed from 1 Jun 2021 to 1 Jun 2023.
- 29 Jan 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2022.
- 24 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2020.